| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.18 | 3e-06 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.18 | 3e-06 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-06 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-06 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-06 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.17 | 5e-06 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.14 | 6e-06 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-06 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-06 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-05 |